Clinical trial
Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease. Identification de Biomarqueurs de SPondylArthrite Chez Les Patients Atteints de Maladie de CROhn présents Dans le MICrobiote fécal.
NCT03983473 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease. Identification de Biomarqueurs de SPondylArthrite Chez Les Patients Atteints de Maladie de CROhn présents Dans le MICrobiote fécal.
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 16, 2021
- Completion date
- December 16, 2027
- Enrollment
- 240 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
crohn disease, spondyloarthritis